Why Choose Private Prescription for Wegovy 1.7mg?
Can I Start Wegovy at 1.7mg Through Private Prescription?
When you search "can I start Wegovy at 1.7mg", you're asking about accessing a specific dose that sits at a crucial point in the escalation protocol. The 1.7mg dose is prescribed for weeks 13-16, representing the final step before reaching the 2.4mg maintenance dose where many patients experience optimal results. Through private prescription services, you can access this dose without the complexities of NHS referral pathways.
The private route offers distinct advantages for patients seeking to start or continue Wegovy at 1.7mg. Rather than navigating GP referrals to specialist weight management services - which can involve 6+ month waiting lists - private prescription allows immediate access following clinical assessment. EverydayMeds provides this service through our GPhC-registered pharmacy (#9012878), ensuring you receive the same genuine Novo Nordisk medication available through NHS prescriptions, but with significantly reduced waiting times.
Wegovy 1.7mg Pricing and Value for Private Patients
Understanding the cost implications when you ask "can I start Wegovy at 1.7mg privately" is essential for treatment planning. Our Wegovy 1.7mg pens are priced at £139.99 each, representing transparent, upfront pricing with no hidden costs. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from DOSE25 for continued savings on their weight management journey.
For patients planning their transition to maintenance dosing, our Elevate Duo bundle combines 1.7mg and 2.4mg pens for £369.99, providing a seamless progression pathway. Alternatively, the Consistency 1.7mg bundle offers two pens of the same dose for £309.99, ideal for patients who may need to remain at this dose for extended periods. These bundle options provide convenience through reduced ordering frequency and assured medication continuity.
Clinical Evidence Supporting Wegovy 1.7mg Treatment Initiation
When considering whether you can start Wegovy at 1.7mg, it's important to understand the clinical foundation supporting this medication. The landmark STEP trials, particularly the research published by Wilding et al. in the New England Journal of Medicine (2021), demonstrated that patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks. The 1.7mg dose represents a critical escalation point where many patients begin experiencing enhanced appetite suppression.
The STEP trial programme included over 4,500 participants across multiple studies, consistently showing that semaglutide's weight management effects become more pronounced at higher doses. However, individual responses vary considerably, and your prescriber will assess whether starting Wegovy at 1.7mg aligns with your specific clinical profile and treatment history. All Wegovy prescriptions must be accompanied by a reduced-calorie diet and increased physical activity for optimal effectiveness.
How Wegovy 1.7mg Works as a GLP-1 Receptor Agonist
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone responsible for regulating appetite and blood sugar levels. When you take the 1.7mg dose, it binds to GLP-1 receptors in your brain, specifically targeting areas responsible for appetite control and food reward pathways. This mechanism helps reduce overall caloric intake by promoting feelings of fullness after smaller meals and may diminish food cravings between meals. The once-weekly injection provides sustained hormone activity, maintaining consistent appetite regulation throughout the week. Unlike some weight management medications that work through stimulant mechanisms, Wegovy's GLP-1 pathway offers a more physiological approach to appetite modulation, working with your body's existing regulatory systems.
Ordering Process for Private Wegovy 1.7mg Prescriptions
The process to answer "can I start Wegovy at 1.7mg" through private prescription begins with our streamlined 3-minute online clinical assessment, designed to capture essential medical information efficiently. Your responses are reviewed by qualified prescribers within our standard 3 working days timeframe, or 24 hours if you select express review during checkout. Once approved, your prescription is processed by our GPhC-registered pharmacy (#9012878) and prepared for next-day delivery using specialised cold-chain logistics. The entire process eliminates the need for GP appointments, specialist referrals, or lengthy NHS waiting lists that can delay treatment initiation. Your Wegovy 1.7mg arrives in temperature-controlled packaging, ensuring medication integrity from pharmacy to your doorstep, ready for immediate storage and use according to the prescribed protocol.
Storage Requirements and Practical Considerations for 1.7mg Dosing
Proper storage is crucial when you start Wegovy at 1.7mg to maintain medication effectiveness throughout the 4-week treatment period. Unopened pens must be stored in your refrigerator between 2-8°C, but once removed, they can remain at room temperature (below 30°C) for up to 6 weeks - offering significant travel flexibility compared to other weight management injections. Each pen uses Novo Nordisk's FlexTouch delivery system, pre-loaded with four weekly doses of 1.7mg semaglutide. The injection should be administered once weekly, on the same day each week, into your abdomen, thigh, or upper arm using the provided needle tips. This dose sits within the escalation protocol specifically designed to minimise gastrointestinal side effects while optimising therapeutic benefit. After 4 weeks at 1.7mg, most patients progress to the 2.4mg maintenance dose, though some may require extended time at this level based on individual tolerance and response.
Why Private Prescription Suits Patients Ready for Wegovy 1.7mg
Patients asking "can I start Wegovy at 1.7mg" often represent experienced users who understand their medication needs and seek efficient access without bureaucratic delays. Private prescription services align perfectly with this patient profile, offering rapid access to specific doses without requiring education about basic weight management principles or extensive counselling sessions that NHS pathways typically mandate. The 1.7mg dose specifically appeals to private patients because it represents a significant investment in advanced treatment, and delays can disrupt carefully planned weight management schedules.
Additionally, private patients at the 1.7mg level often have established relationships with weight management professionals or personal trainers, making the comprehensive support services built into NHS pathways redundant. They value the efficiency of receiving genuine Novo Nordisk medication quickly, allowing them to maintain treatment momentum while pursuing their weight management goals through their preferred support networks. This autonomy and speed of access makes private prescription particularly suitable for the 1.7mg patient demographic.
Securing Your Wegovy 1.7mg Supply Through EverydayMeds
Ready to start Wegovy at 1.7mg through our private prescription service? Simply complete our clinical assessment, which typically takes 3 minutes, and your application will be reviewed by qualified prescribers who understand the specific considerations for this dose level. New customers can use discount code FIRST40 at checkout, whilst returning customers should apply DOSE25 for continued savings on their weight management journey. Visit https://everydaymeds.co.uk/products/wegovy-1-7mg to begin your assessment today. Consider the Elevate Duo bundle if you're planning progression to maintenance dosing, or the Consistency 1.7mg option if you anticipate remaining at this dose level. Our GPhC-registered pharmacy (#9012878) ensures every prescription meets the highest pharmaceutical standards, providing you with confidence in your weight management treatment approach.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
